Search

Search Results

7 results found. Results per page: [ 20 ] [ 40 ] [ 60 ] [ 80 ] [ 100 ] [ 200 ] [ 300 ]

Sort by: [ Publication Date ] [ Score ]

Direction: [ Desc ] [ Asc ]

Year of publication: [ 2026 ] [ 2025 ] [ 2024 ] [ 2023 ] [ 2022 ] [ 2021 ] [ 2020 ] [ 2019 ] [ 2018 ] [ 2017 ] [ 2016 ] [ 2015 ] [ 2014 ] [ 2013 ] [ 2012 ] [ 2011 ] [ 2010 ] [ 2009 ] [ Any ]

• Research PaperVolume 15, Issue 20pp 11244-11267

  CDKN2A was a cuproptosis-related gene in regulating chemotherapy resistance by the MAGE-A family in breast cancer: based on artificial intelligence (AI)-constructed pan-cancer risk model

  Relevance score: 0.00

  Hong Wan, Xiaowei Yang, Guopeng Sang, Zhifan Ruan, Zichen Ling, Mingzhao Zhang, Chang Liu, Xiangyang Hu, Tao Guo, Juntong He, Defeng Liu, Jing Pei

  Keywords: cuproptosis, CDKN2A, breast cancer, artificial intelligence (AI), model

  Published in Aging on October 19, 2023

  Show abstract
• Research PaperVolume 15, Issue 6pp 2136-2157

  The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarker

  Relevance score: 0.00

  Zewei Tu, Xiaolin Wang, Huan Cai, Yilei Sheng, Lei Wu, Kai Huang, Xingen Zhu

  Keywords: CDKN2A, cell senescence, cancer prognosis, biomarker, immunotherapy

  Published in Aging on March 23, 2023

  Show abstract
• Research PaperVolume 16, Issue 12pp 10512-10538

  The crosstalk role of CDKN2A between tumor progression and cuproptosis resistance in colorectal cancer

  Relevance score: 0.00

  Xifu Cheng, Famin Yang, Yuanheng Li, Yuke Cao, Meng Zhang, Jiameng JI, Yuxiao Bai, Qing Li, Qiongfang Yu, Dian Gao

  Keywords: cuproptosis, CDKN2A, bioinformatics, metabolism, radiation therapy

  Published in Aging on June 17, 2024

  Show abstract
• Research PaperVolume 12, Issue 16pp 16357-16367

  Association between Nrf2 and CDKN2A expression in patients with end-stage renal disease: a pilot study

  Relevance score: 0.00

  Keiichi Sumida, Zhongji Han, Ankur A. Dashputre, Praveen K. Potukuchi, Csaba P. Kovesdy

  Keywords: aging, CDKN2A, end-stage renal disease, inflammation, Nrf2

  Published in Aging on July 13, 2020

  Show abstract
• Research PaperVolume 16, Issue 5pp 4116-4137

  PR55α-controlled protein phosphatase 2A inhibits p16 expression and blocks cellular senescence induction by γ-irradiation

  Relevance score: 0.00

  Chitra Palanivel, Lepakshe S. V. Madduri, Ashley L. Hein, Christopher B. Jenkins, Brendan T. Graff, Alison L. Camero, Sumin Zhou, Charles A. Enke, Michel M. Ouellette, Ying Yan

  Keywords: p16, p14, CDKN2A locus, p53, RB, PR55α, PP2A, γ-irradiation

  Published in Aging on March 4, 2024

  Show abstract
• Research PaperVolume 12, Issue 18pp 18676-18692

  Identification of genomic alterations and associated transcriptomic profiling reveal the prognostic significance of MMP14 and PKM2 in patients with pancreatic cancer

  Relevance score: 0.00

  Haiwei Wang, Xinrui Wang, Liangpu Xu, Yingying Lin, Ji Zhang, Hua Cao

  Keywords: pancreatic cancer, KRAS mutation, TP53 mutation, CDKN2A deletion, MMP14

  Published in Aging on September 17, 2020

  Show abstract
• Research PaperVolume 10, Issue 11pp 3371-3381

  LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis

  Relevance score: 0.00

  Junzheng Chen, Xitian Huang, Weijun Wang, Hongcheng Xie, Jianfeng Li, Zhenfen Hu, Zhijian Zheng, Huiyong Li, Lingfang Teng

  Keywords: hepatocellular carcinoma (HCC), long noncoding RNA (lncRNA), CDKN2BAS, ARHGAP18, miR-153-5p

  Published in Aging on November 29, 2018

  Show abstract